Viewing Study NCT03634228

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 11:12 AM

Ignite Modification Date: 2026-01-01 @ 2:27 AM

Study NCT ID: NCT03634228

Status: TERMINATED

Last Update Posted: 2023-06-15

First Post: 2018-08-09

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia

Sponsor: M.D. Anderson Cancer Center

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module